Answer :
Biological response modifiers (BRMs) differ from most drugs on the market in the following ways:
1. **Mechanism of Action**: BRMs work by modifying the body's immune response to diseases such as cancer, whereas traditional drugs typically work by directly targeting specific molecules or pathways in the body.
2. **Specificity**: BRMs often have a more targeted approach, affecting the immune system's response to a particular disease without causing as many side effects on healthy tissues compared to conventional drugs.
3. **Adaptability**: BRMs can sometimes adapt and change their effects based on the body's needs, while conventional drugs usually have a more fixed mechanism of action.
4. **Production**: BRMs are often produced through biotechnological processes, involving genetic engineering or biological systems, while traditional drugs are often chemically synthesized.
5. **Examples**: Examples of BRMs include interferons, interleukins, and monoclonal antibodies, which work by modulating the immune response. In contrast, examples of traditional drugs include antibiotics, pain relievers, and antihypertensive medications that target specific pathogens or symptoms directly.
In summary, biological response modifiers differ from most drugs by their mechanism of action, specificity, adaptability, production methods, and examples of their use in modulating the immune response to diseases.
